KJKishore Kumar Jagadeesan

Kishore Kumar Jagadeesan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kishore Kumar Jagadeesan has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Linking smoking and caffeine biomarkers to socioeconomic and health outcomes through wastewater-based epidemiology: a tool for hypothesis generation

    by Barbara Kasprzyk-Hordern, Kishore Kumar Jagadeesan, Natalie Sims, Davey Jones, Matthew Wade

    Wastewater-based epidemiology (WBE) represents a powerful tool for population health surveillance, however, the systematic integration of wastewater-derived human behavioural markers (WBECI) with socioeconomic and demographic data remains understudied. The aim of this study was to explore the potential of triangulating wastewater chemical markers (WBECI) with population census data to unravel associations between disease prevalence, lifestyle choices and key risk factors associated with nicotine and caffeinated product use. This was critically evaluated in a multi-city (n = 10), national level WBE study in England. Associations of different wastewater markers revealed that smoking WBECIs (nicotine and cotinine) correlate with multi-disease WBECIs (pharmaceuticals used as proxies for disease: cardiovascular diseases (CVDs, pain, asthma, diabetes, infectious disease). Smoking WBECIs also showed strong positive associations with socioeconomic and demographic indicators (ONSSEDI) such as economic deprivation, poor health and low level of education. Triangulation of WBECI and ONSSEDI indicators revealed that cities with lower education outcomes, poor health and the highest deprivation index cluster with smoking as well as with CVD, cancer, diabetes, asthma, infectious disease and pain WBECIs. Conversely, the least deprived city with the highest level of education and good health clustered with caffeine and oxidative stress, which calls for further work to confirm any causal relationships between lifestyle choices, socioeconomic background and health outcomes. Further exploration of correlations reveals pain management and antibiotics usage, illicit drug use, as well as chronic, often lifestyle driven conditions such as CVDs, diabetes, asthma and cancer cluster closely with disability, deprivation, poor health and low level of education. This is especially notable in cities with high deprivation index and could serve as an early warning for city-focussed interventions.

  • Open Access

    Demographic-Driven Wastewater-Based Epidemiology: Refining Population Estimates for Enhanced Chemical Monitoring

    by Kishore Kumar Jagadeesan, Megan Robertson, John Bagnall, Barbara Kasprzyk-Hordern

    Wastewater-based epidemiology (WBE) is a vital tool for public health and environmental monitoring, yet accurate population estimation and demographic profiles within wastewater treatment plant (WWTP) catchments remain a challenge. This study integrates high-resolution 2021 UK Census data, NHS patient registration records, and WWTP chemical parameters to refine population estimates and assess demographic influences on wastewater composition. We compared four statistical models: Simple Approach (SA), Density-Adjusted Bootstrapping (BtD), Density-Adjusted Bootstrapping with Overlap (BtDO), and Bayesian Hierarchical Modeling (ByD), across four diverse UK catchments (12,000-960,000). The BtDO method provided the most consistent estimates, with relative uncertainties as low as 1.5% in larger catchments. Demographic analysis revealed that older populations and higher deprivations correlated with elevated pharmaceutical load (e.g., analgesics, r = 0.92, p < 0.01). Traditional load-based indicators (Chemical Oxygen Demand (COD) and Biological Oxygen Demand (BOD)) significantly overestimated population due to nonhuman contributions, particularly in agricultural areas. This framework, transferable to regions with spatially referenced data, enhances WBE precision for public health surveillance and environmental risk assessment.


  • Open Access

    Predicting pharmaceutical concentrations and assessing risks in the aquatic environment using PERK: A case study of a catchment area in South-West England

    by Kishore Kumar Jagadeesan, Kathryn Proctor, Richard Standerwick, Ruth Barden, Barbara Kasprzyk-Hordern


  • Open Access

    Personal care products use during SARS-CoV-2 pandemic: Environmental and public health impact assessment using wastewater-based epidemiology

    by Nicola Ceolotto, Kishore Jagadeesan, Like Xu, Richard Standerwick, Megan Robertson, Ruth Barden, Julie Barnett, Barbara Kasprzyk-Hordern


  • Open Access

    Multi-biomarker approach for estimating population size in a national-scale wastewater-based epidemiology study

    by Barbara Kasprzyk-Hordern, Kishore Jagadeesan, Natalie Sims, Kata Farkas, Kathryn Proctor, John Bagnall, Megan Robertson, Davey L. Jones, Matthew J. Wade


  • Open Access

    Community-wide infectious disease and immune response tracking using wastewater proteomics

    by Kishore Kumar Jagadeesan, Harry Harry Elliss, Barbara Kasprzyk-Hordern

    The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in a global pandemic, leading to the need for effective surveillance and monitoring strategies. The identification of SARS-CoV-2 peptides and acute phase response proteins in wastewater using mass spectrometry (MS) and the wastewater-based epidemiology concept is a promising tool for the surveillance of infectious diseases. MS provides high specificity and sensitivity for the identification of SARS-CoV-2 peptides in wastewater, allowing for early detection of outbreaks and real-time monitoring of disease trends. The quantification of acute phase response proteins in wastewater provides valuable information on the dynamics of the immune response to SARS-CoV-2, including the kinetics of cytokine production and the levels of acute phase response proteins in wastewater samples. In this study, we developed the first comprehensive mass spectrometry-based framework enabling simultanous tracking of infectious disease spread and community response to facilitate rapid disease management at the community level. SARS-CoV-2 was used as a test pathogen and C-reactive protein (CRP) as an acute phase response protein. The high specificity and sensitivity of MS, combined with the ability to provide a population-level perspective on the spread of the virus, make it a valuable tool for the surveillance of SARS-CoV-2. To our knowledge, this is the first report to use LCMS/MS to measure SARS-CoV-2 and its corresponding acute phase responsive human CRP protein in wastewater.

  • Open Access

    An integrated One Health framework for holistic evaluation of risks from antifungal agents in a large-scale multi-city study using post-acquisition mass spectral data mining and wastewater-based epidemiology pipelines

    by Rawiwan Wattanayon, Kathryn Proctor, Kishore Kumar Jagadeesan, Ruth Barden, Barbara Kasprzyk-Hordern

    A new analytical framework for retrospective mass spectral data mining for antifungal (AFs) agents was developed as part of One Health framework for holistic evaluation of risks from AFs. Post-acquisition data mining of mass spectral repository obtained with a maXis HD QToF mass spectrometer, retrospective quantification and confirmation using bbCID method was undertaken. A large scale, multi-city spatiotemporal profiling programme of antifungal agents was undertaken in the Avon River catchment, South-West England encompassing five contrasting towns/cities served by five major wastewater treatment plants (WWTPs) covering a large geographical area of 2000 km2 and a population of ~1.5 million accounting for > 75% of the overall population in the studied catchment. Key drivers of AFs in the catchment were identified with communal WWTP discharges being the main driver for human AFs (e.g., fluconazole and ketoconazole) and agricultural runoff being the main driver for pesticide AFs (e.g., prochloraz, prothioconazole and tebuconazole). Daily mass loads (DLs) of AF were study/city dependent with several instances of large quantities of AFs (direct disposal) observed. Wastewater-Based Epidemiology (WBE) pipelines were developed to estimate community-wide exposure to antifungal agents and to triangulate the WBE data with per-postcode prescription. Average WBE-estimated human used fluconazole and ketoconazole PNDIs (population normalised daily intake per person) exceeded on average 300 mg day-1 1000inh-1 and 2000 mg day-1 1000inh-1. This is much higher than PNDPs (population normalised daily prescriptions) <40 mg day-1 1000inh-1 and <80 mg day-1 1000inh-1 for fluconazole and ketoconazole respectively. This was expected due to both prescription and OTC (over-the-counter) usage as well as both oral and topical (non-metabolic) application. WBE applied to pesticide-based AFs: prothioconazole and tebuconazole provided variable PNDI estimates across the catchment. Prothioconazole PNDIs were <40,000 mg day-1 1000inh -1, which gave intake per kg of body weight at: 0.43, 0.26, 0.07 mg kg-1 in City A, B and C and is likely due to accounting for external/non-human sources. This is higher than the acceptable daily intake (ADI) set at 0.01 mg kg-1bw day-1, which warrants further study. Intake per kg of body weight estimated using tebuconazole as a xenobiotic chemical residue (XCR) was: 0.86, 1.39, 0.12, 0.13 and 2.7 mg kg-1 in City A-E respectively and is likely due to accounting for external/non-human sources. Intake calculated using the metabolite is in line with ADI: 0.02 and 0.01 mg kg-1 in City B and C respectively, which aligns well with ADI set at 0.03 mg kg-1bw day-1. The environmental risk assessment of the target AAs indicates low/medium risk from fluconazole, prochloraz and tebuconazole, medium risk from epoxiconazole, prothioconazoles metabolite, and tebuconazole, and high risk for prothioconazole in river water. High risk was estimated from fluconazole, epoxiconazole, prothioconazole and its metabolite, tebuconazole, ketoconazole in influent (and/or effluent) samples, which is important due to possible raw sewage discharge via sewer overflows. Due to lack of information on PNEC (predicted no-effect concentration) for other AFs, risk assessment could not be undertaken, which warrants further study.

  • Open Access

    Wastewater-based epidemiology for comprehensive community health diagnostics in a national surveillance study: mining biochemical markers in wastewater

    by Barbara Kasprzyk-Hordern, Natalie Sims, Kata Farkas, Kishore Jagadeesan, Kathryn Proctor, Matthew J. Wade, Davey Jones

    This manuscript showcases results from a large scale and comprehensive wastewater-based epidemiology (WBE) study focussed on multi-biomarker suite analysis of both chemical and biological determinants in 10 cities and towns across England equating to a population of ~7 million people. Multi-biomarker suite analysis, describing city metabolism, can provide a holistic understanding to encompass all of human, and human-derived, activities of a city in a single model: from lifestyle choices (e.g. caffeine intake, nicotine) through to health status (e.g. prevalence of pathogenic organisms, usage of pharmaceuticals as proxy for non-communicable disease, NCD, conditions or infectious disease status), and exposure to harmful chemicals due to environmental and industrial sources (e.g. pesticide intake via contaminated food and industrial exposure). Population normalised daily loads (PNDLs) of many chemical markers were found, to a large extent, driven by the size of population contributing to wastewater (especially NCDs). However, there are several exceptions providing insights into chemical intake that can inform either disease status in various communities or unintentional exposure to hazardous chemicals: e.g. very high PNDLs of ibuprofen in Hull resulting from its direct disposal (confirmed by ibuprofen/2-hydroxyibuprofen ratios) and bisphenol A (BPA) in Hull, Lancaster and Portsmouth likely related to industrial discharge. An importance for tracking endogenous health markers such as 4-hydroxy-2-nonenal-mercapturic acid (HNE-MA, an oxidative stress marker) as a generic marker of health status in communities was observed due to increased levels of HNE-MA seen at Barnoldswick wastewater treatment plant that coincided with higher-than-average paracetamol usage and SARS-CoV-2 prevalence in this community. PNDLs of virus markers were found to be highly variable. Being very prevalent in communities nationwide during sampling, SARS-CoV-2 presence in wastewater was to large extent community driven. The same applies to the fecal marker virus, crAssphage, which is very prevalent in urban communities. In contrast, norovirus and enterovirus showed much higher variability in prevalence across all sites investigated, with clear cases of localised outbreaks in some cities while maintaining low prevalence in other locations. In conclusion, this study clearly demonstrates the potential for WBE to provide an integrated assessment of community health which can help target and validate policy interventions aimed at improving public health and well-being.

  • Open Access

    The burden of city's pain treatment – A longitudinal one year study of two cities via wastewater-based epidemiology

    by Andrew Kannan, Natalie Sims, Angus J. Hold, Kishore Jagadeesan, Richard Standerwick, Ruth Barden, Barbara Kasprzyk-Hordern